| 1 |
Hodgson SV, Morrison PJ, Irving M. Breast cancer genetics:Unsolved questions and open perspectives in an expanding clinical practice. Am J Med Genet C Semin Med Genet,2004,129C(1):56-64.
|
| 2 |
Devereaux QL,Takahashi R,Salvesen GS,et al.X-linked IAP is a direct inhibitor of cell-death proteases.Nature,1997,388(6639):300-304.
|
| 3 |
Adida C,Croty PL,McGrath J,et al.Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation.Am J Pathol,1998,152(1):43-49.
|
| 4 |
Ikeguchi M,Ueda T,Sakatani T,et al.Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma.Diagn Mol Pathol,2002,11(1):33-40.
|
| 5 |
Junhe Li, Wenjing He, Youjian He. The prediction of recurrence and survival of patients with Dukes’B colorectal cancer after curative resection with immunohistochemical detection of survivin and Livin expressions.Chinese-German Journal of Clinical Oncology,2008,7(1):22-26.
|
| 6 |
Notarbartolo M,Cervello M,Giannitrapani L,et al.Expression of IAPs and alternative splice variants in hepatocellular carcinoma tissues and cells.Ann N Y Acad Sci,2004,1028:289-293.
|
| 7 |
Takashima H,Nakajima T,Moriguchi M,et al.In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.Liver Int,2005,25(1):77-84.
|
| 8 |
贺勇,章乐虹,张昊,等.Survivin 及其剪接变异体survivin-△Ex3,survivin-2B mRNA 在乳腺癌中的表达和临床意义.热带医学杂志,2007,7(12):1149-1104.
|
| 9 |
Ryan B,O'Donovan N,Browne B,et al.Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.Br J Cancer,2005,92(1):120-124.
|
| 10 |
Xiong H,Yu S,Zhuang L,et al.Changes of survivin mRNA and protein expression during paclitaxel treatment in breast cancer cells. J Huazhong Univ Sci Technolog Med Sci,2007,27(1):65-67.
|
| 11 |
Ferrara N,Gerber HP,Lecouter J.The biology of VEGF and its receptors.Nat Med,2003,9(6):669-676.
|
| 12 |
Kennedy SM,O’Drscoll L,Purcell R.Prognostic importance of survivin in breast cancer.Br J Cancer,2003,88(7):1077-1083.
|
| 13 |
Howard EM, Lau SK, Lyles RH, et al. Correlation and expression of p53, HER-2, vascular endothelial growth factor (VEGF), and e-cadherin in a high-risk breast-cancer population.Int J Clin Oncol,2004,9(3):154-160.
|
| 14 |
O’Connor DS, Schechner JS, Adida C, et al. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol, 2000,156(2):393-398.
|
| 15 |
Fokman J. Seminons in medicine of the Beth Israel Hospital, Boston. Clinical application of research on angiogenesis. N Engl Med, 1995, 333:1757-1763.
|